Light Mode
$0.5979 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.5979, $0.0805 below the day’s high of $0.6784
-0.17 (-22.17%) / 6M
Momentum, market sentiment, and recent alerts
ONCO reads neutral: price sits above one of the two key moving averages, the 12-month move is -83.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.